Sometimes, these problems arent easy to see at firstbut over time, they can really affect your health
The decision to use these medications should be based on metabolic indications, patient preferences, contraindications, and cost considerations
If you chose beginner (dont track exercise) , then have an educated guess on your activity level
Tirzepatide (Mounjaro, Zepbound) produces around 20.9% body weight loss at 72 weeks in the SURMOUNT-1 trial
Our lead Nurse Practitioner, Susan Jones, an RN, APRN, MSN, FNP with NPI 1639347107, brings extensive experience in managing complex metabolic conditions, ensuring you receive care rooted in deep expertise
If you landed here from our cortisol or perimenopause content, you already know hormonal and stress-driven weight resistance is real